PatenSee specializes in surveillance of dialysis patients.
PatenSee has raised $1.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
PatenSee's investors include MEDX Xelerator.
PatenSee is headquartered in Or Yehuda, Israel.
PatenSee specializes in surveillance of dialysis patients.
PatenSee is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PatenSee — Funding & Investors." VCBacked, February 19, 2025, https://www.vcbacked.co/company/patensee. Accessed August 16, 2026.
VCBacked. (2025). PatenSee — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/patensee
{{cite web |title=PatenSee — Funding & Investors |url=https://www.vcbacked.co/company/patensee |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated